Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective

The therapeutic administration of subcutaneous immunoglobulin (SCIg) offers various advantages over intravenous immunoglobulin (IVIg). This narrative review examines and compares SCIg versus IVIg in chronic inflammatory demyelinating polyneuropathy (CIDP). SCIg is as effective as IVIg but is better...

Descripción completa

Detalles Bibliográficos
Autores principales: Cocito, Dario, Peci, Erdita, Torrieri, Maria Claudia, Clerico, Marinella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671960/
https://www.ncbi.nlm.nih.gov/pubmed/38002576
http://dx.doi.org/10.3390/jcm12226961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671960/
https://www.ncbi.nlm.nih.gov/pubmed/38002576
http://dx.doi.org/10.3390/jcm12226961

Ejemplares similares